TY  - JOUR

T1  - Prospective comparison of RECIST and alternative response assessment criteria in the evaluation of metastatic renal cell cancer patients from phase II of the multi-centre randomised STAR trial

JO  - Annals of Oncology

PY  - 2017/09/01

AU  - Kelly-Morland C

AU  - Zhong J

AU  - Goh V

AU  - Wah T

AU  - Ralph C

AU  - Thistlethwaite F

AU  - Patel P

AU  - Nathan P

AU  - Eisen T

AU  - Gregory W

AU  - McParland L et al

ED  - 

DO  - DOI: 10.1093/annonc/mdx371.044

PB  - Elsevier BV

VL  - 28

SP  - v315

EP  - v315

Y2  - 2024/12/21

ER  -